JPRN-UMIN000024854已完成未知
Clinical study of the effectiveness of edaravone for the oxidative stress in amyotrophic lateral sclerosis - Clinical study for the anti-oxidative stress by edaravone in ALS
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Severe renal dysfunction (Cr > 3.0 mg/dl) and impossible evaluations for motor functions
研究者
相似试验
尚未招募
3 期
Effectivnes of edaravone on ischemic strokeIschemic stroke.Cerebral infarctionIRCT20240224061102N1Yasouj University of Medical Sciences60
招募中
3 期
Efficacy of Edaravone with Thrombolysis in Acute Ischemic StrokeIRCT20210530051440N1Zanjan University of Medical Sciences244
招募中
2 期
Effect of Edaravone in treatment of ALSAmyotrophic Lateral Sclerosis.Progressive muscular atrophyRestrictive lung disease due to amyotrophic lateral sclerosisRestrictive lung mechanics due to alsG12.21IRCT20190324043105N1Esfahan University of Medical Sciences20
已完成
3 期
Edaravone in COVID-19IRCT20200317046797N6Tabriz University of Medical Sciences30
已完成
不适用
Safety and efficacy of Edaravone[Nichiiko] in patients with acute noncardiogenic brain embolismacute noncardiogenic brain embolismJPRN-UMIN000004597Takeshi Yamada20